Role of the C-terminal di-leucine motif of 5-HT₁A and 5-HT₁B serotonin receptors in plasma membrane targeting
The 5-HT₁A and 5-HT₁B serotonin receptors exhibit different subcellular localizations in neurons. Evidence has been reported that the C-terminal domain is involved in the somato-dendritic and axonal targeting of 5-HT₁AR and 5-HT₁BR, respectively. Here we analyzed the consequences of the mutation of...
Gespeichert in:
Veröffentlicht in: | Journal of cell science 2006-10, Vol.119 (20), p.4276-4284 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The 5-HT₁A and 5-HT₁B serotonin receptors exhibit different subcellular localizations in neurons. Evidence has been reported that the C-terminal domain is involved in the somato-dendritic and axonal targeting of 5-HT₁AR and 5-HT₁BR, respectively. Here we analyzed the consequences of the mutation of a di-leucine motif and palmitoylated cysteines within this domain. Replacement of I414-I415 by a di-alanine in 5-HT₁AR led to endoplasmic reticulum (ER) sequestration of the corresponding mutant expressed in cell lines as well as in hippocampal neurons in culture. Furthermore, di-leucine-mutated receptors were unable to bind 5-HT₁A agonists and presented a major deficit in their glycosylation state, suggesting that they are misfolded. By contrast, mutation of the di-leucine motif in the C-terminal domain of 5-HT₁BR had no major consequence on its subcellular targeting. However, in the case of the 1ActB chimera (substitution of the C-terminal domain of the 5-HT₁BR into 5-HT₁AR), this mutation was also found to cause sequestration within the ER. Replacement of palmitoylated cysteines by serines had no consequence on either receptor type. These data indicate that the di-leucine motif of the 5-HT₁AR and 5-HT₁BR tails is implicated in proper folding of these receptors, which is necessary for their ER export. |
---|---|
ISSN: | 0021-9533 1477-9137 |
DOI: | 10.1242/jcs.03189 |